Skip to content

NYXH

Nyxoah SA

NASDAQ · Healthcare · Medical - Instruments & Supplies · BE

$1.48
−0.67%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 5, 2026
EPS estimate
-$0.35
Revenue estimate
$11.4M

Latest reported

Last report date
Aug 5, 2026
EPS actual
-$0.67
EPS estimate
-$0.47
Revenue actual
$8.8M
Revenue estimate
$8.6M

Track record

Trailing twelve quarters

EPS beats (12Q)
1
EPS misses (12Q)
10
EPS in line (12Q)
1
Avg surprise (4Q)
-12.0%
Revenue beats (12Q)
4

Analyst ratings

Sell-side consensus

Consensus
Buy
Price target
$6.00
PT range
$6.00 – $6.00
Analysts
2
2 Buy0 Hold0 Sell
Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
Aug 5, 2026-$0.47-$0.67Miss -42.55%$8.8M
May 12, 2026-$0.54-$0.43Beat 20.37%$7.4M
Mar 19, 2026-$0.65-$0.68Miss -4.62%$6.6M
Nov 13, 2025-$0.61-$0.74Miss -21.31%$2.3M
Aug 18, 2025-$0.62-$0.63Miss -1.61%$1.6M
May 14, 2025-$0.49-$0.63Miss -28.57%$1.2M
Mar 13, 2025-$0.46-$0.49Miss -6.52%$1.3M
Mar 5, 2024-$0.41-$0.41In line$2.0M
May 16, 2023-$0.37-$0.49Miss -32.43%$479.5K
Mar 22, 2023-$0.28-$0.52Miss -85.71%$1.4M
Mar 24, 2022-$0.27-$0.28Miss -2.06%$334.4K
Nov 24, 2021-$0.23-$0.40Miss -75.48%$235.6K

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026